Protein kinase C activation and its pharmacological inhibition in vascular disease.
about
Hydrogen peroxide elicits constriction of skeletal muscle arterioles by activating the arachidonic acid pathwayThe Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?Reactive oxygen species in inflammation and tissue injuryTransactivation of EGFR/PI3K/Akt involved in ATP-induced inflammatory protein expression and cell motilityPresence and Risk Factors for Glaucoma in Patients with Diabetes.Protein kinase C and cerebral vasospasm.Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brain.Mesangial cell protein kinase C isozyme activation in the diabetic milieu.Selective PKC beta inhibition with ruboxistaurin and endothelial function in type-2 diabetes mellitusA comparative profile of methanol extracts of Allium cepa and Allium sativum in diabetic neuropathy in miceOxidative stress in diabetic nephropathy: basic and clinical information.Analysis of cholesteryl esters and diacylglycerols using lithiated adducts and electrospray ionization-tandem mass spectrometryUpdate on the management of diabetic polyneuropathies.Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in ratsPhosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus.Therapeutic potential for protein kinase C inhibitor in vascular restenosis.Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice.Diabetic neuropathy: therapies on the horizon.Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease--do we need to screen our patients?Protein kinase C inhibitors: a patent review (2010 - present).Role of dietary and endogenous antioxidants in diabetes.Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.Role of protein kinase C in podocytes and development of glomerular damage in diabetic nephropathy.Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms.Breviscapine attenuatted contrast medium-induced nephropathy via PKC/Akt/MAPK signalling in diabetic mice.Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to alpha-adrenoceptor stimulation.Rho kinase and protein kinase C involvement in vascular smooth muscle myofilament calcium sensitization in arteries from diabetic rats.Hypoxia-induced increases in glucose uptake do not cause oxidative injury or advanced glycation end-product (AGE) formation in vascular endothelial cells.Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes.High glucose-suppressed endothelin-1 Ca2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells.Alterations in rat coronary vasoreactivity and vascular protein kinase C isoforms in Type 1 diabetes.Rottlerin causes pulmonary edema in vivo: a possible role for PKCdelta.Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.Evolving Mechanisms of Vascular Smooth Muscle Contraction Highlight Key Targets in Vascular Disease.
P2860
Q27316765-BD13F486-ED99-4C33-82AF-4619396B8AE2Q28082434-E5BAB60F-5EE0-4B7D-ACA3-5036AAD6AF31Q28396273-DD06EB55-CF95-48C7-8C63-2B3BBF48C389Q28572445-DBABCBAB-5FED-432D-8BD5-D2E9D11C222BQ30244246-E1D50CDB-D8C0-4DB9-BBC5-7C0267DECB00Q34327417-3854F05B-7DE9-4A87-96C5-A004CBF6079AQ34452590-5BDF3916-81F2-461B-AEC2-CD537182B105Q34629037-ED8AA4BD-486A-4DF2-9B57-CBA997847B00Q34931190-0B93A029-AA98-4C9F-8ED8-E603EE60C56CQ35036226-E1F8E44A-C4C4-4F0A-98D2-1FBE1A522AF8Q35087692-DA6F6373-DA5B-4C58-8C83-255B761643A8Q35154107-8964C9E0-C162-4C60-8641-6FC17D36B08FQ35178801-998CD90D-B7D3-4CA9-8851-9A2C2CC4FFCFQ36287281-EA2BA26E-6E07-41A4-8D34-04DB35CCA1EFQ36294444-7A345B7D-6D0B-4F2A-B163-2A7B46B96929Q36480056-562D53B9-2315-4318-A226-0F02608E6C06Q37399929-379ACD95-ED14-4E49-ABE5-3F62278130C5Q37585663-3EF40CAB-5F59-4440-96E9-C1D63CA7E6D8Q37724503-A03ADEE1-8EC8-4BFE-94C0-436835E6B424Q38116565-0AD04F16-ED3E-4532-B42B-B3AEF56DAB33Q38192085-21B8C473-5720-473B-8E7C-A9F87EEFB42CQ38265843-0C740F15-EC67-4114-9DB2-BE69A9F5CE13Q38270180-422A1334-BE2E-4846-BDC2-99C09512C748Q40236633-5DE02058-388A-46BA-ACC1-C0BD99EC238AQ40683122-C24CE528-7A27-4132-8C0E-DD7F690ED9B0Q41790090-AE86720E-04CD-4A5E-816E-703597F67D95Q42251635-06ED99EA-95E0-47EB-ADBE-961575D45DF5Q42933590-3067408B-9EE2-4754-8A16-6ED8560E9B32Q44222544-BF1DAD88-3BF7-4D77-BE05-12B2313007B8Q44488100-DDABD118-5770-460C-A3FA-FBCDB68904E2Q44550390-D936C30D-CC7C-40EB-AEBE-752FF4936F85Q46977319-3017B629-5B3D-4781-B5F7-C62AA47E76E8Q47131231-1B51EDB7-4362-4984-9234-995361AADE89Q49923465-1F72F84F-0771-43D0-A796-B806346045B2
P2860
Protein kinase C activation and its pharmacological inhibition in vascular disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Protein kinase C activation and its pharmacological inhibition in vascular disease.
@ast
Protein kinase C activation and its pharmacological inhibition in vascular disease.
@en
Protein kinase C activation and its pharmacological inhibition in vascular disease.
@nl
type
label
Protein kinase C activation and its pharmacological inhibition in vascular disease.
@ast
Protein kinase C activation and its pharmacological inhibition in vascular disease.
@en
Protein kinase C activation and its pharmacological inhibition in vascular disease.
@nl
prefLabel
Protein kinase C activation and its pharmacological inhibition in vascular disease.
@ast
Protein kinase C activation and its pharmacological inhibition in vascular disease.
@en
Protein kinase C activation and its pharmacological inhibition in vascular disease.
@nl
P2860
P1433
P1476
Protein kinase C activation and its pharmacological inhibition in vascular disease.
@en
P2093
P2860
P304
P356
10.1177/1358836X0000500307
P577
2000-01-01T00:00:00Z